Singleton J Matthew
- SEC CIK
- 0001243514
No open-market purchases or sales filed in the past year.
Current role at each company
- VKTX Viking Therapeutics, Inc.Directoras of Jan 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Singleton J Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2024 (view filing) | Oct 25 | Same day | Singleton J MatthewDirector | SSaleCommon Stock, par value $0.00001 per share | −16.0K | $79.50 | −$1.27M | −62.7%9.50K after | 10b5-1 |
| Sep 20, 2024 (view filing) | Sep 20 | Same day | Singleton J MatthewDirector | SSaleCommon Stock, par value $0.00001 per share | −10.3K | $69.50 | −$715.9K | −52.0%9.50K after | 10b5-1 |
| Aug 22, 2024 (view filing) | Aug 21 | 1 day | Singleton J MatthewDirector | SSaleCommon Stock, par value $0.00001 per share | −5.70K | $69.72 | −$397.4K | −37.5%9.50K after | 10b5-1 |
| Aug 19, 2024 (view filing) | Aug 19 | Same day | Singleton J MatthewDirector | SSaleCommon Stock, par value $0.00001 per share | −16.0K | $62.22 | −$995.4K | −62.7%9.50K after | 6 lots10b5-1 |
| Aug 14, 2024 (view filing) | Aug 14 | Same day | Singleton J MatthewDirector | SSaleCommon Stock, par value $0.00001 per share | −20.8K | $57.53 | −$1.20M | −68.6%9.50K after | 2 lots10b5-1 |